Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii

Queen's Medical Center1 个研究点分布在 1 个国家目标入组 20 人2024年10月10日

适应症Contingency Managment Methamphetamine Use Disorder

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Contingency Managment
发起方: Queen's Medical Center
入组人数: 20
试验地点: 1
主要终点: TEA Outcomes at 6 and 12-weeks
状态: 已完成
最后更新: 上个月

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use.

The main objectives are to:

Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury
To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program.

Participants will:

Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit
Complete Treatment Effectiveness Assessments at 6 and 12-weeks
Engage in a qualitative interview at the end of the CM program

注册库

clinicaltrials.gov

开始日期

2024年10月10日

结束日期

2025年12月30日

最后更新

上个月

研究类型

Interventional

研究设计

Single Group

性别

All

研究者

发起方

Queen's Medical Center

责任方

Sponsor

入排标准

入选标准

•Admitted trauma patients
•Age greater than 18 years old
•Urine drug screen positive for methamphetamines during the current hospitalization
•Report at least weekly methamphetamine use
•First methamphetamine use greater than 6 months prior to injury
•Report at least 4 DSM-V Amphetamine-Type Substance Use Disorder symptoms (at least moderate disease)
•Glasgow Coma Scale ≥13 upon arrival to the emergency department
•Ability to understand and participate in study procedures
•Ability to communicate in English

排除标准

•Active psychosis (reporting auditory or visual hallucinations)
•Under ongoing cardiorespiratory monitoring
•Evidence of moderate or severe traumatic brain injury
•Patients who are known to be pregnant
•Individuals incarcerated at the time of their hospitalization
•Individuals lacking capacity to provide, or are otherwise unable or unwilling to provide written informed consent

结局指标

主要结局

TEA Outcomes at 6 and 12-weeks

时间窗: From enrollment to 6 and 12-weeks

Treatment Effectiveness Assessment (TEA): This assessment asks individuals to respond to changes in four domains following a drug treatment program: substance use, health, lifestyle, and community. The score for each domain can range from 1 (no change or not much) to 10 (much better), for a total score of 4-40. This score allows for the prioritization of each participants values, and therefore does not require strict abstinence to demonstrate benefit from drug treatment.